Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Common Equity (2016 - 2026)

Axogen has reported Common Equity over the past 17 years, most recently at $244.8 million for Q1 2026.

  • For Q1 2026, Common Equity rose 132.34% year-over-year to $244.8 million; the TTM value through Mar 2026 reached $244.8 million, up 132.34%, while the annual FY2025 figure was $128.8 million, 24.0% up from the prior year.
  • Common Equity for Q1 2026 was $244.8 million at Axogen, up from $128.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $244.8 million in Q1 2026 and troughed at $93.2 million in Q1 2024.
  • A 5-year average of $111.8 million and a median of $101.4 million in 2022 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: decreased 14.33% in 2022 and later soared 132.34% in 2026.
  • Year by year, Common Equity stood at $101.0 million in 2022, then fell by 5.28% to $95.7 million in 2023, then grew by 8.62% to $103.9 million in 2024, then rose by 24.0% to $128.8 million in 2025, then surged by 90.0% to $244.8 million in 2026.
  • Business Quant data shows Common Equity for AXGN at $244.8 million in Q1 2026, $128.8 million in Q4 2025, and $120.8 million in Q3 2025.